Loading…
Integra LifeSciences has signed a definitive agreement to acquire Derma Sciences for $7.00 per share in cash, expanding its regenerative technology and advanced wound care capabilities. The transaction is expected to close at the end of Q1 2017.
“Integra LifeSciences Holdings Corporation announced today that it has signed a definitive agreement to acquire Derma Sciences Inc.”globenewswire.com
Summarized from public sources; check the original articles before acting on it.